SCHEMBL29622130

SCHEMBL29622130

O=C1Cc2cc(O)cnc2N1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MB P02144 1/20 0.60
ABL1 P00519 2/20 0.58
CHEK1 O14757 1/20 0.58
AURKA O14965 1/20 0.58
DAPK3 O43293 1/20 0.58
PRKD3 O94806 1/20 0.58
MAP4K4 O95819 1/20 0.58
NTRK1 P04629 1/20 0.58
CSF1R P07333 1/20 0.58
RET P07949 1/20 0.58
MET P08581 1/20 0.58
PDGFRB P09619 1/20 0.58
PIM1 P11309 1/20 0.58
FGFR1 P11362 1/20 0.58
PDGFRA P16234 1/20 0.58
FLT1 P17948 1/20 0.58
LTK P29376 1/20 0.58
GRK5 P34947 1/20 0.58
KDR P35968 1/20 0.58
MAP2K2 P36507 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17081150 0.84 MB (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL20066164 0.81 CDK5 (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL152602 0.78 GSK3B (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL728499 0.78 ABL1 (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL5201194 0.78 ABL1 (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL23016925 0.78 ABL1 (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL13259405 0.78 ABL1 (0.58) MBABL1CHEK1AURKADAPK3
SCHEMBL2953884 0.77 ABL1 (0.54) MBABL1CHEK1AURKADAPK3
SCHEMBL13940835 0.77 ABL1 (0.54) MBABL1CHEK1AURKADAPK3
SCHEMBL5893559 0.77 ABL1 (0.58) ABL1CHEK1AURKADAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240722-A1 OXINDOLES AND METHODS OF USE THEREOF Aligos Therapeutics, Inc. (US) 2023-09-13 EP disclosed
WO-2022099066-A1 OXINDOLES AND METHODS OF USE THEREOF ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 WO disclosed